首页> 外国专利> GRAFTED MACROMOLECULAR CONJUGATES OF DOXORUBICIN WITH ANTICANCER ACTIVITY AND METHOD OF THEIR PREPARATION

GRAFTED MACROMOLECULAR CONJUGATES OF DOXORUBICIN WITH ANTICANCER ACTIVITY AND METHOD OF THEIR PREPARATION

机译:具有抗癌活性的阿霉素的嫁接大分子缀合物及其制备方法

摘要

A polymeric drug, in which a cancerostatic connected via spacers containing hydrolytically cleavable hydrazone bonds is bound to a water-soluble polymeric carrier prepared on the basis of a N-(2-hydroxypropyl)methacrylamide copolymer, wherein the structure of the polymeric drug consists of the main chain of N-(2-hydroxypropyl)methacrylamide carrying the cancerostatic and another chain of N-(2-hydroxypropyl)methacrylamide - a graft, the molecular weights of the main chain and the grafts are selected so that both the main chain before bonding of the grafts and the grafts themselves are excludable from the body after degradation, while the total molecular weight of the grafted polymer exceeds the exclusion limit of the body, where said polymeric drug has a structure selected from 1a, 1b, 1c, 1d, 2, 3a, 3b, 4a, 4b, 4c and 5 structures disclosed in the description and a method of preparation thereof.
机译:一种高分子药物,其中通过含可水解裂解的bonds键的间隔基连接的抗癌药与基于N-(2-羟丙基)甲基丙烯酰胺共聚物制得的水溶性高分子载体结合,其中高分子药物的结构由带有抗癌活性的N-(2-羟丙基)甲基丙烯酰胺的主链和N-(2-羟丙基)甲基丙烯酰胺的另一链-接枝,选择主链和接枝的分子量,使主链在降解后,移植物和移植物本身的键合可以从体内排除,而接枝聚合物的总分子量超过了人体的排斥极限,其中所述聚合药物的结构选自1a,1b,1c,1d,说明书中公开的2、3a,3b,4a,4b,4c和5个结构及其制备方法。

著录项

  • 公开/公告号EA017073B1

    专利类型

  • 公开/公告日2012-09-28

    原文格式PDF

  • 申请/专利权人 ZENTIVA K.S.;

    申请/专利号EA20090000453

  • 发明设计人 TOMAS;PETR;KAREL;TOMAS;BLANKA;

    申请日2007-09-18

  • 分类号A61K47/48;

  • 国家 EA

  • 入库时间 2022-08-21 17:24:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号